Sling offers lasting benefit for stress urinary incontinence

Sling offers lasting benefit for stress urinary incontinence
Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability, according to research published in the November issue of The Journal of Urology.

(HealthDay)—Stress urinary incontinence treatment with a distal urethral polypropylene sling procedure is associated with excellent long-term efficacy and durability, according to research published in the November issue of The Journal of Urology.

Lisa Rogo-Gupta, M.D., of the Geffen School of Medicine at the University of California in Los Angeles, and colleagues conducted a prospective study involving 69 consecutive patients who underwent a distal urethral polypropylene sling procedure for the treatment of . Long-term follow-up data at a minimum of 11 years were available for 30 patients (mean age at follow-up, 73 years).

Of the patients lost to follow-up, 10 were deceased and five were cognitively impaired. At follow-up, the researchers found that 48 percent of patients reported no symptoms of stress urinary incontinence and 63 percent reported not being bothered by stress urinary incontinence. Overall, symptoms improved an average of 64 percent at 11 years, compared with 81 percent at five years. Based on symptom scores, 82 percent of patients were rated as successes, while 80 percent were rated as successes based on bother scores.

"The distal urethral polypropylene sling procedure has excellent long-term durability in the treatment of stress urinary incontinence, in addition to low morbidity and low cost as previously described," the authors write. "When choosing an anti-incontinence procedure, durability should be considered in light of patient age given that the theoretical advantages of long-term durability are limited by and mortality."

One author disclosed to Astellas and .

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

New hope for rare disease drug development

9 hours ago

Using combinations of well-known approved drugs has for the first time been shown to be potentially safe in treating a rare disease, according to the results of a clinical trial published in the open access Orphanet Journal of ...

Three weeks since last Ebola case in Mali: WHO

12 hours ago

Mali has not had a case of Ebola for three weeks, the World Health Organization said Wednesday, completing one of the two incubation periods the country needs to be declared free of the virus.

Migraine may double risk for facial paralysis

13 hours ago

Migraine headache may double the risk of a nervous system condition that causes facial paralysis, called Bell's palsy, according to a new study published in the December 17, 2014, online issue of Neurology, the medical journa ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.